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R e c e n t l y  t h e  M 1 7 S  1 g e n e ,  e n c o d i n g  an e p i d e r m a l  an-  
t i g e n  t h o u g h t  to  p l a y  a r o l e  in ce l l  a d h e s i o n ,  w a s  
m a p p e d  to  c h r o m o s o m e  b ands  1 7 q  11 - q  12 ,  p l a c i n g  it  in  
t h e  v i c i n i t y  o f  the  g e n e  for  the  g e n e t i c  d i s o r d e r  neurof i -  
b r o m a t o s i s  I ( N F  1). T h e  p l e o m o r p h i c  c u t a n e o u s  l e s i o n s  
o f  N F  1 a n d  t h e  p r e c e d e n t  for  o t h e r  g e n e s  b e i n g  e m b e d -  
d e d  w i t h i n  t h e  N F 1  g e n e  p r o m p t e d  us  to  i n v e s t i g a t e  
w h e t h e r  t h e  M 1 7 S 1  g e n e  m a p p e d  n e a r ,  or  w i t h i n ,  the  
N F 1  g e n e .  G e n e t i c  l i n k a g e  a n a l y s e s  r e v e a l e d  tha t  
M 1 7 S 1  w a s  t i g h t l y  l i n k e d  to  N F 1  a n d  m a p p e d  w i t h i n  
t h e  i n t e r v a l  b o u n d e d  b y  D 1 7 S 5 8  a n d  D 1 7 S 5 4 .  P h y s i c a l  
m a p p i n g  o f  an  M 1 7 S 1  c D N A  on  s o m a t i c  ce l l  h y b r i d s ,  
y e a s t  ar t i f i c ia l  c h r o m o s o m e s ,  a n d  an N F 1  p a t i e n t  w i t h  
a d e l e t i o n  i n v o l v i n g  an e n t i r e  N F  1 a l l e l e  d e m o n s t r a t e d  
tha t  M 1 7 S 1  is  l o c a t e d  at  l e a s t  1 8 0  k b  c e n t r o m e r i c  to  
t h e  N F  1 g e n e .  T h e  d i s t a n c e  b e t w e e n  the  g e n e s  s u g g e s t s  
tha t  M 1 7 S 1  is  u n l i k e l y  to  c o n t r i b u t e  to  the  N F 1  p h e n o -  
t y p e  s i n c e  a g r o s s  c h r o m o s o m a l  r e a r r a n g e m e n t  w o u l d  
b e  r e q u i r e d  to  d i s r u p t  e x p r e s s i o n  o f  b o t h  g e n e s .  © 1992 
Academic Press, Inc. 
INTRODUCTION 
The epidermis is composed of keratinocytes that  are 
continually differentiating and being pushed upward 
from the mitotic basal layer at the dermal-epidermal 
junction to the outer surface of the skin. The identifica- 
tion and study of differentiation-specific gene products 
has been a valuable strategy for investigating the struc- 
ture, composition, and function of normal skin and the 
pathobiology of skin disorders (Fuchs, 1990; Fine et  al., 
1991). Several years ago, a 35-kDa human epidermal 
protein was identified by the murine monoclonal anti- 
body ECS-1 isolated from a mouse injected with cultured 
human foreskin keratinocytes (Negi et  al., 1986). The 
ECS-1 antibody induced a complement-enhanced epi- 
dermal cell detachment activity suggesting that  the 35- 
kDa protein may play a role in cell adhesion (Negi et  al., 
1986). The cDNA encoding the 35-kDa protein, named 
ESA for epidermal surface antigen, was recently cloned, 
and the DNA sequence predicted a peptide of 290 amino 
acids in length. The cloning, sequence, and tissue-speci- 
fic expression of ESA will be reported elsewhere (W. 
Schroeder, unpublished data). 
The ESA gene, designated M17S1, was mapped by in  
s i tu  hybridization to human chromosome bands 1 7 q l l -  
q12 (Schroeder et  al., 1991). We found it intriguing that 
M17S1 was located in the vicinity of the gene for neuro- 
fibromatosis 1, a disorder with multiple skin manifesta- 
tions, located at 17q11.2 (Schmidt et  al., 1987; Ledbetter 
et  al., 1989). Neurofibromatosis 1 (NF1) is a common 
autosomal dominant genetic disorder affecting 1 of 3000 
individuals (Crowe et  al., 1956). The skin manifestations 
include cutaneous and subcutaneous neurofibromas, 
caf6-au-lait spots (hyperpigmented skin patches), and 
freckling in the armpit and groin. Neurofibromas can 
also be of the plexiform type, affecting a bundle(s) of 
nerves; hyperpigmentation and hypertrichosis (exces- 
sive hair) of the skin overlying the tumor are common. 
In addition to the skin manifestations, Lisch nodules of 
the iris, optic glioma, and certain bony abnormalities are 
diagnostic features of NF1. Affected individuals com- 
monly have associated findings such as macrocephaly, 
scoliosis, learning disabilities, and increased risk of ma- 
lignancy. Reviews of the clinical presentation of NF1 
have been published (Riccardi, 1992; Stumpf et  al., 1988; 
Rubenstein and Korf, 1990; Huson et  al., 1989). 
The NF1 gene is large and structurally complex. The 
gene, estimated at 300 kb in length, produces a tran- 
script of approximately 13 kb, and a predicted protein, 
designated neurofibromin, of 2818 amino acids (Wallace 
et  al., 1990; Marchuk et  al., 1991). During the search for 
the NF1 transcript, three small genes that  mapped 
within a single large intron of the NF1 gene were identi- 
fied, transcribed from the alternate strand (Cawthon et  
al., 1990a,b; O'Connell et  al., 1990; Viskochil et  al., 1991). 
Two of the embedded genes, EVI2A and EVI2B, are the 
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h u m a n  h o m o l o g s  o f  m u r i n e  s e q u e n c e s  w h e r e  r e t r o v i r a l  
i n t e g r a t i o n  r e s u l t s  in  m u r i n e  m y e l o i d  t u m o r  e x p r e s s i o n  
( B u c h b e r g  e t  al., 1990). T h e  t h i r d  gene ,  o l i g o d e n d r o -  
c y t e - m y e l i n  g l y c o p r o t e i n  ( O M G P ) ,  is a c o m p o n e n t  o f  
u n k n o w n  f u n c t i o n  o f  c e n t r a l  n e r v o u s  s y s t e m  m y e l i n  
( M i k o l  a n d  S t e f a n s s o n ,  1988). 
T h e  m o l e c u l a r  b a s e s  for  t h e  i n t e r -  a n d  i n t r a f a m i l i a l  
v a r i a b l e  e x p r e s s i v i t y  t h a t  is a h a l l m a r k  o f  t h e  N F 1  dis-  
o r d e r  h a v e  y e t  to  be  i den t i f i ed .  A ro le  o f  N F 1  locus  he t -  
e r o g e n e i t y  as  a m a j o r  c o n t r i b u t o r y  f a c t o r  to  i n t e r f a m i l i a l  
v a r i a b i l i t y  a p p e a r s  u n l i k e l y .  G e n e t i c  l i n k a g e  s t u d i e s  b y  
a n  i n t e r n a t i o n a l  c o n s o r t i u m  i n v o l v i n g  142 m u l t i g e n e r a -  
t i o n a l  N F 1  f a m i l i e s  s u p p o r t  t h e  h y p o t h e s i s  o f  a s ing le  
N F 1  gene  in  t h e  p e r i c e n t r o m e r i c  r e g i o n  o f  c h r o m o s o m e  
17 ( s u m m a r i z e d  b y  G o l d g a r  e t  al., 1989). G e n e t i c  l i n k a g e  
d a t a  a n d  d i r e c t  m o l e c u l a r  i d e n t i f i c a t i o n  o f  N F 1  gene  
m u t a t i o n s  i n d i c a t e d  t h a t  t h e  s a m e  gene  was  r e s p o n s i b l e  
for  b o t h  f a m i l i a l  a n d  s p o r a d i c  c a s e s  o f  t h e  d i s o r d e r  (S te -  
p h e n s  e t  al., 1987; U p a d h y a y a  e t  al., 1990; W a l l a c e  e t  al., 
1991; K a y e s  e t  al., 1992). T h i s  is  a n  i m p o r t a n t  o b s e r v a -  
t i o n  s ince  a p p r o x i m a t e l y  50% of  ca ses  a r e  due  to  a p p a r -  
e n t  n e w  m u t a t i o n  in  t h e  N F 1  gene  (Crowe  e t  al., 1956; 
R i c c a r d i ,  1992). I t  h a s  b e e n  p r o p o s e d  t h a t  m u t a t i o n s  
d i s r u p t i n g  a n  e m b e d d e d  gene ,  in  a d d i t i o n  to  t h e  N F 1  
gene ,  m a y  c o n t r i b u t e  to  i n t e r f a m i l i a l  v a r i a b i l i t y  ( W a l -  
lace  e t  al., 1990; C a w t h o n  e t  al., 1990a).  H o w e v e r ,  
s c r e e n i n g  t h e  t h r e e  k n o w n  e m b e d d e d  genes  o f  N F 1  p a -  
t i e n t s  for  m u t a t i o n s  h a s  b e e n  u n p r o d u c t i v e  ( O ' C o n n e l l  
e t  al., 1990; C a w t h o n  e t  al., 1990b,  1991; V i s k o c h i l  e t  al., 
1991). I t  r e m a i n s  to  be  d e t e r m i n e d  w h e t h e r  a n y  genes  
e m b e d d e d  in,  o r  a d j a c e n t  to ,  t h e  N F 1  gene  c o n t r i b u t e  to  
t h e  v a r i a b l e  p h e n o t y p e .  
T h e  s k i n  m a n i f e s t a t i o n s  a n d  v a r i a b l e  e x p r e s s i v i t y  o f  
t h e  N F 1  d i s o r d e r  a n d  t h e  p r e c e d e n t  for  o t h e r  genes  
m a p p i n g  w i t h i n  t h e  N F 1  gene  p r o m p t e d  us  to  d e t e r m i n e  
w h e t h e r  t h e  M 1 7 S 1  gene  m a p p e d  n e a r ,  o r  w i t h i n ,  t h e  
N F 1  gene .  
MATERIALS AND METHODS 
Families and D N A  markers. Previously, we constructed a genetic 
map of eight loci in the pericentromeric region of chromosome 17 
using data collected on 50 NF1 families (Stephens et al., 1987, 1989). 
The markers, with locus designations in parentheses, included p17H8 
(D17Z1), A10-41 (D17S71), pEW301 (D17S58), pEW206 (D17S57), 
pEW207 (D17S73), pEW203 (D17S54), L581 (D17S37), and L946 
(D17S36). For the current study, we chose 18 families with individuals 
previously determined to have a recombination event in the chromo- 
some 17 pericentromeric region (Stephens et al., 1989); these families 
were BAY& BAY13, BAY14, BAY17, BAY21, BAY25, BAY28, 
BAY31, BAY34, BAY35, BAY40, BAY45, BAY58, BAY77, BAY78, 
UMI4, UMI5, and UMI16. Family prefixes, designating the institu- 
tion where the families were ascertained, are as established previously 
by the NF1 international genetic linkage consortium (Stephens et al., 
1987, 1989; Goldgar et al., 1989). Accordingly, NF1 patients/families 
ascertained at the University of Washington are designated with the 
UWA prefix. In this study, these 18 families were typed with seven 
additional probe/enzyme systems (locus designations in parentheses) 
including pESA2-Pst I  (M17S1; W. Schroeder, unpublished data), 













FIG. 1. Inheritance of a RFLP detected by M17S1 gene. South- 
ern blot ofPstI-digested DNA from individuals of family UMI4 hybrid- 
ized with pESA2. The pedigree position and affected status for each 
family member is given above the appropriate lane. Solid symbols, 
NFl-affected individuals; open symbols, unaffected individuals; 
squares, male; circles, female. A1 and A2 indicate the two alleles; c 
designates invariant fragments. The outer lanes contain DNA size 
standards; sizes are given in kilobasepairs. 
MspI (CRYB1; fl-crystallin gene), pVAW215R3-TaqI  (D17S120) 
(Fain et al., 1989), pHHH202-RsaI  (D17S33; White et al., 1987), and 
pTH17.19-BglII  (D17S82; O'Connell et al., 1989). pESA2 is a 2.0-kb 
partial cDNA of M17S1. Two NF1 cDNAs were used in the YAC 
studies; GE2 is a partial cDNA from the 5' end, and P5 is a partial 
cDNA from the 3' end of the gene (Wallace et al., 1990; Marchuk et al., 
1991). 
Somatic cell hybrids, cell lines, and YACs. DCR-1 and NF13 are 
human-mouse somatic cell hybrids carrying human derivative chro- 
mosomes from two unrelated NF1 patients with translocation break- 
points within the NF1 gene. DCR-1 has a derivative chromosome 1 
(lqter-p34.3: : 17ql 1-qter; Schmidt et al., 1987; Menon et al., 1989) 
and NF13 a derivative chromosome 22 (22pter-22qll.2::17qll.2- 
17qter; Ledbetter et al., 1989). The NF13 breakpoint maps approxi- 
mately 60 kb q-distal to the DCR-1 breakpoint (O'Connell et al., 
1990). The SP3-10 hybrid contains a human derivative chromosome 
15 (15pter-q22:: 17qll-17qter; Sheer et al., 1983, 1985). MH22.6 car- 
ries an intact chromosome 17 as its only human genomic component 
(van Tuinen et al., 1987). The LMTk- mouse cell line was the fusion- 
recipient for construction of DCR-1, NF13, and MH22.6 (van Tuinen 
et al., 1987). Cell lines were obtained from the American Type Culture 
Collection (Rockville, MD). UWA106-3 is an immortalized lympho- 
blastoid cell line from an NF1 patient with an extensive deletion en- 
compassing the entire NF1 paternal allele and four flanking loci in- 
cluding D17S120, D17Sl15, D17S57, and D17S73 (Kayes et al., 1992). 
The three overlapping yeast artificial chromosome (YAC) clones 
A43A9, D8F4, and A113D7 form a contig that spans the NF1 gene 
(Marchuk et al., 1992). DNA from non-YAC-bearing yeast was a gift 
of Lee Hartwell. 
D N A  hybridization. Genomic DNA was purified from peripheral 
blood, immortalized lymphoblastoid cell lines, somatic ceil hybrids 
EPIDERMAL ANTIGEN GENE MAPS NEAR NF1 
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Lod Score at 0 of 
Locus 0.001 0.01 0.05 0.10 0.20 0.30 0.40 0.50 ~ 
NF1 6.61 6.49 5.96 5.27 3.82 2.31 0.90 0.00 0.00 6.62 
D17S57 3.60 3.53 3.17 2.73 1.82 0.96 0.28 0.00 0.00 3.61 
D17S73 3.30 3.24 2.96 2.59 1.83 1.08 0.42 0.00 0.00 3.31 
D17S54 0.31 2.19 3.04 2.95 2.17 1.23 0.39 0.00 0.06 3.06 
D17S58 1.51 2.43 2.77 2.62 1.97 1.19 0.46 0.00 0.05 2.77 
D17S71 2.67 2.61 2.37 2.05 1.40 0.76 0.22 0.00 0.00 2.67 
D17S120 2.40 2.36 2.19 1.96 1.47 0.95 0.43 0.00 0.00 2.41 
D17S37 0.30 1.24 1.66 1.60 1.16 0.63 0.18 0.00 0.06 1.67 
D17Zl 0.01 0.96 1.44 1.47 1.18 0.74 0.26 0.00 0.08 1.48 
D17Sl15 0.90 0.89 0.81 0.72 0.52 0.30 0.09 0.00 0.00 0.90 
D17Sl17 0.90 0.88 0.79 0.68 0.45 0.23 0.07 0.00 0.00 0.90 
D17S33 0.60 0.59 0.54 0.47 0.32 0.17 0.05 0.00 0.00 0.60 
CRYB1 0.30 0.29 0.26 0.21 0.13 0.06 0.02 0.00 0.00 0.30 
D17S36 -4.79 -1.86 -0.06 0.46 0.59 0.37 0.11 0.00 0.17 0.61 
Note.  Pairwise lod scores calculated at 0 m = Of; 2, maximum lod score, 0, recombination fraction at £. 
(Bell et al., 1981), or YAC-containing yeast (Sherman et al., 1986). 
Five micrograms of human genomic DNA or 13 #g of DNA from hy- 
brid cell lines was digested with restriction enzymes (5 U/#g; 
Boehringer-Mannheim, Indianapolis) according to the manufac- 
turer 's directions, with the exception of TaqI and MspI,  which were 
digested at 67°C and room temperature, respectively, to minimize par- 
tial digestion products (Donis-Keller et  al., 1987). The extent of the 
digestion was assessed in a second parallel test reaction (Schumm et 
al., 1988): a volume (6 #1) of the original digestion reaction, containing 
1 #g of human DNA, was added to 1 #g X DNA. Complete digestion 
was assumed if the X DNA digest appeared complete upon ethidium 
bromide staining after agarose gel electrophoresis of the test reac- 
tions. Any original DNA-digested samples that  were judged as incom- 
plete were redigested with 2-5 U/#g DNA for 8-12 h. Digested sam- 
ples were electrophoresed through 0.8% agarose at 1.7 V/cm for 24-30 
h. Gels were denatured 30 min in 0.5 M NaOH and 1.5 M NaC1 and 
transferred overnight by capillary action to Zetabind membrane 
(AMF Cuno, Meriden, CT). For detection of restriction fragment 
length polymorphisms (RFLPs), cloned human DNA inserts were la- 
beled in s i tu  with their vector sequences by primer extension (Fein- 
berg and Vogelstein, 1983). For hybridization to membranes with 
NF1-YAC DNAs, which carry plasmid sequences homologous to 
many of the probes, the human DNA insert was isolated from the 
probe vector by restriction enzyme digestion, electrophoresis, and re- 
covery on NA45 DEAE membrane (Schleicher and Schuell, Keene, 
NH) before labeling. Hybridization was as previously described 
(Donis-Keller et al., 1987). 
The copy number of the M17S1 gone in deletion patient UWA106-3 
was assayed by densitometry. A Southern blot membrane with DNA 
from UWA106-3 and unrelated, non-NF individuals was sequentially 
hybridized to M17S1 and L946. L946 (Donis-Keller et al., 1987) was 
chosen to control for variation in DNA concentration among the sam- 
ple lanes because it lies outside the deleted region of UWA106-3 
(Kayes et al., 1992) and hybridizes to fragments of similar size as 
M17S1. The resulting autoradiograms were scanned with a Hoefer 
GS300 densitometer and Macintosh II computer. The density ratio of 
the 3.1-kb invariant band revealed by M17S1 (Fig. 3B) to the density 
of the 2.4-kb invariant band revealed by L946 (Fig. 3C) was deter- 
mined for the control individual in Figs. 3B and 3C, lane 3, and 
UWA106-3, Figs. 3B and 3C, lane 4. 
Linkage analysis. Two-point and multipoint linkage analyses were 
performed with the program CRI-MAP Version 2.4 (P. Green, unpub- 
lished data; Barker etal . ,  1987; Donis-Keller et al., 1987). The ALL 
option of the program was used to calculate the likelihood that  the 
M17S1 locus mapped in any one marker interval on a map of 15 peri- 
centromeric loci. The unique order of loci shown in Fig. 2 is based on 
genetic and physical data (Goldgar et al., 1989; Fain et  al., 1989; Foun- 
tain etal . ,  1989); there are two ambiguities in locus order as summa- 
rized in Fig. 5. The CHROMPICS option of the program, which dis- 
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FIG.  2. Position of the M17S1 locus on the genetic map of chro- 
mosome 17. The relative odds, calculated from the likelihood values, 
in favor of placement of the M17S1 gene in a given locus interval are 
shown. Sex-averaged distances are given in cM (Goldgar et al., 1989). 
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FIG.  3. Physical mapping of M17S1. Autoradiograms resulting 
from hybridization of the M17S1 cDNA pESA2 and L946 to a South- 
ern membrane ofPstI-digested genomic and somatic cell hybrid DNA. 
Human-specific fragments are labeled for M17S1; A1 is the 2.1-kb 
allele, A2 is the 1.4- and 0.6-kb allele, and c indicates the 3.1- and 
1.1-kb constant  fragments. (A) 13 ttg DNA from murine and hybrid 
cell lines, hybridized to M17S1. Lane 1, MH22.6; lane 2,  LMTk-;  lane 
3,  DCR-1; lane 4, NF13; lane 5, SP3-10. (B) 4 #g DNA from periph- 
eral blood leukocytes of four unrelated individuals, hybridized to 
M17S1. Lanes 1, 2, and 3, unaffected control individuals; lane 4, 
NF1 deletion pat ient  UWA106-3. The samples in A and B were coelec- 
trophoresed, transferred, and hybridized on a single membrane; the 
photograph of the autoradiogram was cut apart  to simplify presenta- 
t ion of the data. (C) The same section of membrane shown in B,  
hybridized to L946. Arrowhead indicates the 2.4-kb band  used in densi- 
tometry. 
1.4 and 0.6 kb in size. Allele frequencies, based on 134 
chromosomes of unrelated Caucasian individuals, were 
0.21 for allele 1 and 0.79 for allele 2. The polymorphic 
information content  (Botstein et al., 1980) was calcu- 
lated at 0.27. 
Genetic Mapping of the M17S1 Gene 
The segregation of alleles for the PstI RFLP of M17S1 
and RFLPs for 6 other loci described under Materials 
and Methods were determined in the 18 NFl-affected 
families. Pairwise lod scores between M17S1 and 5 of 
these loci, plus 8 loci from our previous studies and the 
NF1 phenotype (Stephens et al., 1987, 1989), are given in 
Table 1, in order of decreasing lod score. The pairwise 
lod scores, calculated under the hypothesis of equal re- 
combination frequency in males and females, show that  
the M17S1 and NF1 genes are tightly linked giving a 
maximum lod score of 6.62 at a 0 of 0.00. Lod scores 
exceeding 3.0, significant evidence in favor of linkage, 
were also obtained for D17S57, D17S73, and D17S54 
(Table 1). No recombination events were detected be- 
tween M17S1 and either D17S57 or D17S73 (Table 1). 
Pairwise lod scores between M17S1 and 10 other loci 
were positive but not statistically significant (Table 1). 
Two-point lod scores for M17S1 and D17S82 are not 
shown since no meioses were jointly informative at both 
loci. Significant evidence in favor of excluding tight link- 
age between the most q-distal locus, D17S36, and 
M17S1 was obtained (Table 1). A lod score of -2 .0  at 0 = 
0.009 excludes M17S1 from a location within approxi- 
mately 1% recombination either side of the D17S36 
locus. 
A B 
1 2 3 4  1 2 3 4  
plays the maximum likelihood phase choice for ordered loci on the two 
chromosomes of each offspring, was used to detect loci involved in 
recombination events. Data for all loci involved in recombination 
events were checked for accuracy; all families have been screened for 
possible nonpaterni t ies  (Stephens et al., 1989). 
RESULTS 
RFLP Revealed by M17S1 
To facilitate genetic mapping, we screened DNA from 
five unrelated individuals digested with 11 different re- 
striction enzymes for an RFLP revealed by the M17S1 
gene. DNA fragments of variant length were observed in 
the PstI-digested samples; no fragment size variations 
were observed in digests involving BamHI, BglII, EcoRI, 
HindIII, HinfI, HpaII, MspI, PvuII, TaqI, or RsaI (data 
not shown). The variant length PstI fragments were 
shown to represent the two alleles of a single locus by 
their segregation pat tern in 20 multigenerational fami- 
lies; a representative result is shown in Fig. 1. Allele I is 
2.1 kb in length and allele 2 consists of two fragments, 
1.6 
FIG.  4. Mapping of M17S1 on NF1-YACs. (A) autoradiogram 
resulting from hybridization of the M17S1 cDNA pESA2 to a South- 
ern membrane ofEcoRI-digested DNA from NF1-YAC-bearing yeast. 
Lane 1, molecular weight marker, size given in kb; lane 2,  YAC D8F4; 
lane 3, YAC Al13D7; lane 4,  YAC A43A9. (B) Autoradiogram of the  
Southern membrane in A after rehybridization to the NF1 cDNAs 
GE2 and P5. 
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FIG.  5. Map of the chromosome 17 pericentromeric region. The upper line diagram shows the relative order of loci, including the NF1 gene 
(Stephens et  al., 1987; Goldgar et al., 1989; Fain et al., 1989; O'Connell et al., 1989). Diagram is not  drawn to scale; refer to Fig. 2 for genetic 
distances. Two ambiguities in locus order are indicated above the map; the order of D17S120 and D17Sl17 may be reversed and the position of 
D17Sl15 with respect to D17S57 and  D17S73 is not  known. Below the map, subchromosomal fragments present  in the hybrid cell lines and the 
deletion pat ient  UWA106-3 are indicated. The expanded region is a physical map of the NF1 gene, drawn to scale, showing the endpoints  of 
chromosome 17 segments carried by the translocation hybrids DCR-1 and NF13 and the NF1-YACs. YAC D8F4 is chimeric; the wavy line 
represents human  DNA from an unknown locus (Marchuk et al., 1992). The approximate positions of the NF1 cDNAs GE2 and P5 are 
indicated. +, Hybridization to M17S1 on Southern blot analysis; - ,  no significant hybridization to M17S1. 
Multipoint genetic linkage analyses were performed 
to map the M17S1 gene relative to NF1 and other loci in 
the 17q proximal region. Figure 2 summarizes the rela- 
tive probability that  M17S1 maps to any one of 10 inter- 
locus intervals. Significant evidence in favor of exclud- 
ing placement (relative odds >1:100) of M17S1 outside 
of the interval bounded by D17S58 and D17S54 was ob- 
tained (Fig. 2). 
Physical Mapping of the M17S1 Gene 
Somatic cell hybrids carrying subchromosomal re- 
gions of human chromosome 17 were used to refine the 
location of the M17S1 gene. The locations of the break- 
point(s) carried by each hybrid are diagramed in Fig. 5. 
All hybrid cell lines display fragments that  comigrate 
with murine-specific fragments in the LMTk-  murine 
cell line (Fig. 3A, lane 2). MH22.6, a human chromosome 
17 hybrid (lane 1), displays the expected human-specific 
fragments of the M17Sl allele 2 and constant bands. 
While the two hybrids carrying derivatives of balanced 
translocations in the NF1 gene, DCR-1 (lane 3) and 
NF13 (lane 4), show no human-specific fragments, 
M17S1 homologous bands were observed in the hybrid 
SP3-10 (lane 5). SP3-10 clearly has the two fragments of 
the M17S1 allele 2 and the constant bands. These data 
map the M17S1 gene to the region between the SP3-10 
and DCR- 1 breakpoints. 
To determine whether the M17S1 gene was embedded 
within the NF1 gene, we hybridized the M17S1 cDNA to 
three overlapping NFI-YACs that  together span the en- 
tire >300 kb of the NF1 gene (Marchuk et al., 1992; Fig. 
5). As shown in Fig. 4A, the NF1-YACs carried no frag- 
ments homologous to M17S1. The membrane was hy- 
bridized in the same bag as the membrane shown in Fig. 
3, demonstrating that  the hybridization reaction was suc- 
cessful. To confirm the presence and integrity of NF1- 
YAC DNA on the blot, it was stripped and simulta- 
neously rehybridized to P5 and GE2, two NF1 cDNA 
fragments known to map within the YAC clones (Mar- 
chuk et al., 1992; Fig. 5). Figure 4B demonstrates that  
the quality of the Southern blot was sufficient to gener- 
ate a detectable signal upon hybridization to a single- 
copy gene probe. In a separate experiment, no detectable 
hybridization was observed between the M17S1 cDNA 
and DNA from non-YAC-bearing yeast (data not 
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shown). These data show unambiguously that  the 
M17S1 gene is not embedded within the NF1 gene. 
To further define the location of M17S1 in the region 
centromeric to NF1, it was mapped on UWA106-3, an 
NF1 patient that  we have recently identified with an 
extensive deletion encompassing an entire NF1 allele 
(Materials and Methods; Kayes e t  al., 1992; Fig. 5). The 
M17S1 alleles of UWA106-3 are shown in Fig. 3B in 
comparison to three unrelated, unaffected individuals 
displaying the three possible allele combinations at the 
locus. Lane 4 shows that  UWA106-3 is either homozy- 
gous or hemizygous for allele 2 of M17S1. The copy num- 
ber of M17S1 in DNA from peripheral blood for patient 
UWA106-3 was determined by densitometry of the auto- 
radiograms in Figs. 3B and 3C as described under Mate- 
rials and Methods. The M17S1/L946 density ratios were 
equivalent for the control individual and UWA106- 
3:0.807 and 0.779, respectively. These data show that  
the deletion carried by UWA106-3 does not include the 
M17S1 gene. 
DISCUSSION 
Using both genetic and physical breakpoints, we have 
mapped the gene for a novel epidermal antigen, M17S1, 
to a small q-proximal interval of chromosome 17. Ge- 
netic mapping was facilitated by the identification and 
characterization of a two-allele M17S1 polymorphism 
with a PIC of 0.27 revealed by the restriction enzyme 
P s t I  (Fig. 1). Ten other restriction enzymes tested did 
not reveal any apparent polymorphism with the M17S1 
cDNA, pESA2. 
As predicted from the in  s i t u  hybridization data 
mapping M17S1 to chromosome bands 17qll-q12 
(Schroeder et  al., 1991), lod score analyses demonstrated 
that  M17S1 was linked to loci in this region. The geno- 
type for the M17S1 P s t I  polymorphism and the poly- 
morphisms for seven additional probe/enzyme systems 
were determined for individuals of 18 NF1 families. 
These families were chosen from our large repository of 
NF1 families because they would provide the maximum 
information; each family contained individuals with pre- 
viously defined recombination events in the chromo- 
some 17 pericentromeric region (Stephens e t  al., 1989). 
Significant evidence in favor of tight linkage between 
M17S1 and four pericentromeric loci was obtained: NF1, 
D17S57, D17S73, and D17S54 (Table 1). 
Multipoint linkage analyses were performed to map 
the location of the M17S1 gene relative to other pericen- 
tromeric loci. Significant evidence in favor of placement 
of the M17S1 gene between the loci D17S58 and D17S54 
(Fig. 2), an interval known to contain the NF1 gene, was 
obtained. These data, in addition to the in  s i t u  data 
mapping M17S1 to chromosome band 17qll-q12 
(Schroeder et  al., 1991), map the M17S1 gene to a 13-cM 
interval between the centromere (D17Z1) and D17S54 
(Figs. 2 and 5). 
Since finer genetic mapping of M17S1 would require a 
large number of meioses or a more informative RFLP, 
we chose to use physical breakpoints to further localize 
the gene. The M17S1 gene was not found in two hybrid 
cell lines (DCR-1 and NF13) carrying derivative chro- 
mosomes 17 with breakpoints in the NF1 gene (Figs. 3 
and 5). These data narrowed the interval containing the 
M17S1 gene to a location between the centromere 
(D17Zl) and the DCR-1 breakpoint near the 3' end of 
the NF1 gene (Fig. 5). The presence of M17S1 homolo- 
gous sequences in the hybrid SP3-10, which carries the 
entire NF1 gene plus additional centromeric-proximal 
sequences (Fig. 5, van Tuinen et  al., 1987; Fain et  al., 
1989; Fountain et  al., 1989), suggested that  the M17S1 
gene was either near the 5' end, or embedded within, the 
NF1 gene. 
To determine whether the M17S1 gene was embedded 
within the NF1 gene, we hybridized the pESA2 cDNA to 
three NF1-YACs that  form a contig encompassing the 
entire NF1 gene (Marchuk et  al., 1992). As shown in Fig. 
4 and summarized in Fig. 5, M17S1 homologous se- 
quences were not detected in any of the YACs. These 
data demonstrate unambiguously that  the M17S1 gene 
is not embedded within the NF1 gene. The possibility 
that  M17S1 may map adjacent to the 5' end of the NF1 
gene was also excluded; YAC A43A9 carries approxi- 
mately 180 kb of DNA upstream of the 5' end of the NF1 
gene (Marchuk et  al., 1992; Fig. 5). These data narrowed 
the interval carrying the M17S1 gene to a location be- 
tween the hybrid SP3-10 breakpoint and 180 kb centro- 
mere-proximal to the NF1 gene (Fig. 5). 
Additional data mapped the M17S1 gene between the 
SP3-10 translocation breakpoint and the deletion 
breakpoint of individual UWA106-3. UWA106-3 is an 
NF1 patient carrying a large deletion encompassing an 
entire NF1 allele and contiguous genetic material 
(Kayes e t  al., 1992; Fig. 5). Densitometric analysis 
showed that  UWA106-3 had two copies of the M17S1 
gene (Fig. 3), proving that  M17S1 was located outside 
this deletion. 
In our previous study, the proximal extent of the dele- 
tion in UWA106-3 had not been established unambigu- 
ously with respect to the 5' end of the NF1 gene (Kayes et  
al., 1992). D17S120, the most centromeric-proximal 
locus deleted in UWA106-3, was thought to map 5' to the 
NF1 gene since a microcell fusion breakpoint separated 
the two, but conclusive evidence was not available (Fain 
et  al., 1989). The NF1-YAC contig clones provided the 
opportunity to precisely define the proximal deletion 
breakpoint of UWA106-3. Southern blot hybridization 
of the YACs proved that  D17S120 is not within the NF1 
gene (data not shown). Therefore, the UWA106-3 dele- 
tion breakpoint lies a minimum of 180 kb centromeric to 
the NF1 promotor. These data confirm our previous 
conclusion that  the NF1 phenotype appears to be the 
result of inactivation of one allele, rather than by the 
action of an abnormal neurofibromin protein product 
(Kayes e t  al., 1992) and provide a well-defined break- 
point for mapping other loci in the 17q centromere- 
proximal region. 
The interval between the SP3-10 translocation and 
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U W A 1 0 6 - 3  d e l e t i o n  b r e a k p o i n t s  c o n t a i n s  a t  l e a s t  one  
a d d i t i o n a l  gene ,  ~ - c r y s t a l l i n ,  a n d  t h e  a n o n y m o u s  
loc i  D 1 7 S 3 3  ( p H H H 2 0 2 ) ,  D 1 7 S 8 2  ( p T H 1 7 . 1 9 ) ,  a n d  
D 1 7 S l 1 6  ( p V A W 2 1 1 )  ( F o u n t a i n  e t  al., 1989; F a i n  e t  al., 
1989). T h e  e s t i m a t e d  m i n i m u m  g e n e t i c  d i s t a n c e  o f  t h e  
i n t e r v a l  is  0.6 c M ,  t h e  s e x - a v e r a g e d  g e n e t i c  d i s t a n c e  b e -  
t w e e n  N F 1  a n d  D 1 7 S 3 3  ( G o l d g a r  e t  al., 1989). 
p H H H 2 0 2 ,  t h e  p r o b e  for  l ocus  D17S33 ,  d e t e c t s  a n d  l ies  
< 2 2 0  k b  d i s t a l  to  t h e  S P 3 - 1 0  b r e a k p o i n t  ( F o u n t a i n  e t  al., 
1989). 
A l t h o u g h  t h e  M 1 7 S 1  gene  is t i g h t l y  l i n k e d  to ,  a n d  
p h y s i c a l l y  n e a r  t h e  N F 1  gene ,  t h e  r e s u l t s  o f  t h i s  s t u d y  
s h o w  t h a t  i t  is n o t  e m b e d d e d  w i t h i n  t h e  N F 1  gene,  n o r  is 
i t  p h y s i c a l l y  c lose  e n o u g h  to  l i k e l y  b e  d i s r u p t e d  b y  t h e  
m a j o r i t y  o f  m u t a t i o n s  c a u s i n g  t h e  N F 1  d i s o r d e r .  O n l y  a 
l a rge  d e l e t i o n  o r  c o m p l e x  c h r o m o s o m a l  r e a r r a n g e m e n t  
c o u l d  i n v o l v e  t h e  M 1 7 S 1  gene ,  l o c a t e d  > 1 8 0  k b  p r o x i m a l  
to  t h e  N F 1  gene;  such  r e a r r a n g e m e n t s  o f  t h e  N F 1  gene  
a p p e a r  to  be  u n c o m m o n  ( U p a d h y a y a  e t  al., 1990). T h e r e -  
fore ,  d e f e c t s  in  M 1 7 S 1  e x p r e s s i o n  p r o b a b l y  do  n o t  con-  
t r i b u t e  to  t h e  s k i n  m a n i f e s t a t i o n s  o r  v a r i a b l e  e x p r e s s i v -  
i t y  o f  N F 1 .  
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